ExodusPoint Capital Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,111
Closed -$677K 2032
2023
Q2
$677K Buy
+49,111
New +$737K 0.01% 1243
2022
Q3
Sell
-90,718
Closed -$1.8M 2201
2022
Q2
$1.8M Buy
+90,718
New +$2.03M 0.02% 823
2021
Q3
Sell
-7,517
Closed -$239K 2508
2021
Q2
$239K Sell
7,517
-1,481
-16% -$47K ﹤0.01% 1883
2021
Q1
$317K Buy
+8,998
New +$313K ﹤0.01% 1631
2020
Q3
Sell
-10,477
Closed -$373K 2122
2020
Q2
$373K Buy
+10,477
New +$364K 0.01% 1210
2020
Q1
Sell
-18,625
Closed -$438K 1508
2019
Q4
$438K Buy
18,625
+3,986
+27% +$89.3K 0.01% 937
2019
Q3
$264K Buy
+14,639
New +$242K 0.01% 957

Other funds holding PETS

ExodusPoint Capital Management's PETS Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 49,111 shares — an estimated $677K sold.

ExodusPoint Capital Management first reported a position in PETS in Q3 2019 and held it in 7 quarters. The position peaked at $1.8M in Q2 2022. 139 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

  • ExodusPoint Capital Management reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 49,111 PetMed Express shares in Q3 2023, an estimated $677K.
  • ExodusPoint Capital Management first reported a position in PetMed Express in Q3 2019 and held it in 7 quarters.
  • ExodusPoint Capital Management's PetMed Express position peaked at $1.8M in Q2 2022.
  • 139 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.